Atjaunināt sīkdatņu piekrišanu

Elsevier's 2022 Intravenous Medications: A Handbook for Nurses and Health Professionals 38th edition [Spiral bound]

(Clinical Pharmacy Specialist and Coordinator of Clinical Pharmacy Services, Chesapeake Regional Medical Center; President, Drug Information Consultants, Chesapeake, Virginia)
  • Formāts: Spiral bound, 1408 pages, height x width: 229x152 mm, weight: 1650 g
  • Izdošanas datums: 02-Aug-2021
  • Izdevniecība: Elsevier - Health Sciences Division
  • ISBN-10: 0323825095
  • ISBN-13: 9780323825092
Citas grāmatas par šo tēmu:
  • Spiral bound
  • Cena: 61,64 €*
  • * Šī grāmata vairs netiek publicēta. Jums tiks paziņota lietotas grāmatas cena
  • Šī grāmata vairs netiek publicēta. Jums tiks paziņota lietotas grāmatas cena.
  • Daudzums:
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Formāts: Spiral bound, 1408 pages, height x width: 229x152 mm, weight: 1650 g
  • Izdošanas datums: 02-Aug-2021
  • Izdevniecība: Elsevier - Health Sciences Division
  • ISBN-10: 0323825095
  • ISBN-13: 9780323825092
Citas grāmatas par šo tēmu:

Find the essential information you need to safely administer more than 400 intravenous drugs! For more than 45 years, Gahart's Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for comprehensive drug coverage, unparalleled accuracy, and an intuitive quick-access format. In addition to updated drug interactions, precautions, alerts, and patient teaching instructions for all existing IV drugs, the 2022 edition includes approximately 10 new monographs of the most recent IV drugs to be approved by the FDA. Administering intravenous drugs is a critical task - inaccurate or out-of-date information is not an option. Known as the #1 IV drug handbook on the market, and with its history of impeccable accuracy, Gahart's annual publication gives you the extra confidence and guidance you need to safely and effectively treat patients.

  • Monographs on more than 400 IV drugs
  • offer an impressive breadth of coverage that goes well beyond any comparable drug reference.
  • Updated annual publication prevents you from referencing outdated information.
  • Additional drug monographs are provided on the companion Evolve website.
  • 45-year history of impeccable accuracy reinforces the importance of safe IV drug administration.
  • Perfect depth of information equips you with everything that is needed for safe administration of IV drugs - nothing more, nothing less.
  • Proven, clinically optimized format keeps all dosage information for each drug on either a single page or a two-page spread to prevent hand contamination by having to turn a page.
  • Highlighted Black Box Warnings and relevant content make locating critical information fast and easy.
  • Special circumstances in blue-screened text call attention to important circumstances that may not warrant Black Box Warnings.
  • Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients.
  • Dilution and dosage charts within monographs provide quick access to essential clinical information.
  • Convenient, alphabetical format organizes all drug monographs by generic name, allowing you to find any drug in seconds.
  • NEW! Drug monographs for newly approved drugs by the FDA
  • provide you with the most current drug information.
  • Updates on drug interactions, precautions, alerts, and more have been made throughout the guide to reflect all changes to existing medications.
Evolve website information, inside front cover General Dilution Charts ii
How to Use This Book iii
Preface x
Format and Content of Intravenous Medications xvi
Key to Abbreviations xx
Important IV Therapy Facts xxii
Resources xxiv
IV Drugs
1(1357)
Appendix A Recommendations for the Safe Use and Handling of Cytotoxic Drugs 1358(1)
Appendix B FDA Pregnancy Categories 1359(1)
Appendix C U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) 1359(1)
Appendix D Information for Patients Receiving Immunosuppressive Agents 1360(1)
Appendix E Recently Approved Drugs 1361(1)
Index 1362
Shelly Collins, PharmD, has decades of clinical experience in which she has been responsible for overseeing system-wide pharmaceutical safety.